Hudson Capital Management LLC Acquires 3,219 Shares of Colgate-Palmolive (NYSE:CL)

Hudson Capital Management LLC increased its position in shares of Colgate-Palmolive (NYSE:CL) by 15.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 23,410 shares of the company’s stock after buying an additional 3,219 shares during the quarter. Hudson Capital Management LLC’s holdings in Colgate-Palmolive were worth $1,845,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the company. Wolff Wiese Magana LLC purchased a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $25,000. Grant Street Asset Management Inc. purchased a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $28,000. TRU Independence Asset Management 2 LLC bought a new position in Colgate-Palmolive during the fourth quarter valued at $29,000. Encompass Wealth Advisors LLC bought a new position in Colgate-Palmolive during the fourth quarter valued at $29,000. Finally, Accel Wealth Management bought a new position in shares of Colgate-Palmolive in the fourth quarter worth $33,000. 76.47% of the stock is owned by hedge funds and other institutional investors.

Shares of CL traded down $0.10 during trading hours on Wednesday, hitting $79.63. The company had a trading volume of 136,128 shares, compared to its average volume of 4,960,117. The firm has a market cap of $67.49 billion, a P/E ratio of 25.44, a P/E/G ratio of 3.83 and a beta of 0.59. The stock’s 50 day moving average price is $77.13 and its 200 day moving average price is $80.50. The company has a quick ratio of 0.62, a current ratio of 0.97 and a debt-to-equity ratio of 6.50. Colgate-Palmolive has a 52-week low of $65.54 and a 52-week high of $86.41.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Thursday, January 28th. The company reported $0.77 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.76 by $0.01. The company had revenue of $4.32 billion for the quarter, compared to analysts’ expectations of $4.15 billion. Colgate-Palmolive had a return on equity of 383.88% and a net margin of 16.65%. Colgate-Palmolive’s quarterly revenue was up 7.7% on a year-over-year basis. During the same period last year, the firm earned $0.73 earnings per share. On average, research analysts expect that Colgate-Palmolive will post 3.05 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 14th. Investors of record on Wednesday, April 21st will be paid a $0.45 dividend. The ex-dividend date of this dividend is Tuesday, April 20th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.44. This represents a $1.80 annualized dividend and a dividend yield of 2.26%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 62.19%.

A number of equities analysts have recently commented on CL shares. Stifel Nicolaus lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $83.00 price target for the company. in a report on Thursday, January 28th. Credit Suisse Group raised Colgate-Palmolive from an “underperform” rating to a “neutral” rating and lifted their price objective for the company from $70.00 to $80.00 in a research note on Monday, February 1st. Royal Bank of Canada lowered Colgate-Palmolive from an “outperform” rating to a “sector perform” rating and set a $90.00 price objective for the company. in a research note on Monday, January 4th. Berenberg Bank raised Colgate-Palmolive from a “sell” rating to a “hold” rating and set a $76.00 price objective for the company in a research note on Tuesday, January 26th. Finally, Sanford C. Bernstein initiated coverage on Colgate-Palmolive in a research note on Tuesday, January 19th. They set an “underperform” rating and a $77.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $81.91.

In related news, CTO Patricia Verduin sold 1,513 shares of the firm’s stock in a transaction dated Tuesday, February 16th. The stock was sold at an average price of $77.16, for a total value of $116,743.08. Following the sale, the chief technology officer now directly owns 45,545 shares of the company’s stock, valued at $3,514,252.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jennifer Daniels sold 20,692 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, February 4th. The shares were sold at an average price of $78.65, for a total value of $1,627,425.80. Following the sale, the insider now directly owns 55,585 shares in the company, valued at $4,371,760.25. The disclosure for this sale can be found here. Insiders sold 30,810 shares of company stock worth $2,418,650 over the last three months. 0.78% of the stock is owned by insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment's products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.

Recommended Story: Non-Fungible Token (NFT)

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.